Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hemophilia Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hemophilia Therapeuticsmarket, defines the market attractiveness level of Hemophilia Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hemophilia Therapeutics industry, describes the types of Hemophilia Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hemophilia Therapeutics market and the development prospects and opportunities of Hemophilia Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hemophilia Therapeutics market in Chapter 13.
By Player:
Expression Therapeutics
Pfizer Inc
Biogen Idec Inc
Genetics Institute
Baxter International Inc
Novo Nordisk A/S
Bayer AG
Alpha Therapeutics Corporation
Swedish Orphan Biovitrum AB
By Type:
hemophilia A
hemophilia B
hemophilia C
By End-User:
Hospitals
Clinics
Ambulatory Surgical Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hemophilia Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hemophilia Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hemophilia Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hemophilia Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hemophilia Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Hemophilia Therapeutics Consumption (2017-2022)
-
7.2 United States Hemophilia Therapeutics Consumption (2017-2022)
-
7.3 Europe Hemophilia Therapeutics Consumption (2017-2022)
-
7.4 China Hemophilia Therapeutics Consumption (2017-2022)
-
7.5 Japan Hemophilia Therapeutics Consumption (2017-2022)
-
7.6 India Hemophilia Therapeutics Consumption (2017-2022)
-
7.7 South Korea Hemophilia Therapeutics Consumption (2017-2022)
8 Region and Country-wise Hemophilia Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Hemophilia Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Hemophilia Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Hemophilia Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Hemophilia Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Hemophilia Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Hemophilia Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Hemophilia Therapeutics Consumption Forecast (2022-2028)
9 Global Hemophilia Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Hemophilia Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global hemophilia A Consumption and Growth Rate (2017-2022)
-
9.1.2 Global hemophilia B Consumption and Growth Rate (2017-2022)
-
9.1.3 Global hemophilia C Consumption and Growth Rate (2017-2022)
-
9.2 Global Hemophilia Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
10 Global Hemophilia Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Hemophilia Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global hemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global hemophilia C Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hemophilia Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Hemophilia Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hemophilia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hemophilia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hemophilia Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hemophilia Therapeutics Market Competitive Analysis
-
14.1 Expression Therapeutics
-
14.1.1 Expression Therapeutics Company Details
-
14.1.2 Expression Therapeutics Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Expression Therapeutics Hemophilia Therapeutics Product and Service
-
14.2 Pfizer Inc
-
14.2.1 Pfizer Inc Company Details
-
14.2.2 Pfizer Inc Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Inc Hemophilia Therapeutics Product and Service
-
14.3 Biogen Idec Inc
-
14.3.1 Biogen Idec Inc Company Details
-
14.3.2 Biogen Idec Inc Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biogen Idec Inc Hemophilia Therapeutics Product and Service
-
14.4 Genetics Institute
-
14.4.1 Genetics Institute Company Details
-
14.4.2 Genetics Institute Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Genetics Institute Hemophilia Therapeutics Product and Service
-
14.5 Baxter International Inc
-
14.5.1 Baxter International Inc Company Details
-
14.5.2 Baxter International Inc Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Baxter International Inc Hemophilia Therapeutics Product and Service
-
14.6 Novo Nordisk A/S
-
14.6.1 Novo Nordisk A/S Company Details
-
14.6.2 Novo Nordisk A/S Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novo Nordisk A/S Hemophilia Therapeutics Product and Service
-
14.7 Bayer AG
-
14.7.1 Bayer AG Company Details
-
14.7.2 Bayer AG Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bayer AG Hemophilia Therapeutics Product and Service
-
14.8 Alpha Therapeutics Corporation
-
14.8.1 Alpha Therapeutics Corporation Company Details
-
14.8.2 Alpha Therapeutics Corporation Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Alpha Therapeutics Corporation Hemophilia Therapeutics Product and Service
-
14.9 Swedish Orphan Biovitrum AB
-
14.9.1 Swedish Orphan Biovitrum AB Company Details
-
14.9.2 Swedish Orphan Biovitrum AB Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Swedish Orphan Biovitrum AB Hemophilia Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hemophilia Therapeutics
-
Figure Hemophilia Therapeutics Picture
-
Table Global Hemophilia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hemophilia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hemophilia Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hemophilia Therapeutics Consumption by Country (2017-2022)
-
Figure United States Hemophilia Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Hemophilia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Hemophilia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Hemophilia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Hemophilia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hemophilia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Hemophilia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hemophilia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hemophilia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hemophilia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hemophilia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hemophilia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global hemophilia A Consumption and Growth Rate (2017-2022)
-
Figure Global hemophilia B Consumption and Growth Rate (2017-2022)
-
Figure Global hemophilia C Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global hemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global hemophilia C Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hemophilia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hemophilia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Expression Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Expression Therapeutics Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Expression Therapeutics Hemophilia Therapeutics Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Hemophilia Therapeutics Product and Service
-
Table Biogen Idec Inc (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Inc Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Inc Hemophilia Therapeutics Product and Service
-
Table Genetics Institute (Foundation Year, Company Profile and etc.)
-
Table Genetics Institute Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genetics Institute Hemophilia Therapeutics Product and Service
-
Table Baxter International Inc (Foundation Year, Company Profile and etc.)
-
Table Baxter International Inc Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Inc Hemophilia Therapeutics Product and Service
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Hemophilia Therapeutics Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Hemophilia Therapeutics Product and Service
-
Table Alpha Therapeutics Corporation (Foundation Year, Company Profile and etc.)
-
Table Alpha Therapeutics Corporation Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alpha Therapeutics Corporation Hemophilia Therapeutics Product and Service
-
Table Swedish Orphan Biovitrum AB (Foundation Year, Company Profile and etc.)
-
Table Swedish Orphan Biovitrum AB Hemophilia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Swedish Orphan Biovitrum AB Hemophilia Therapeutics Product and Service
-
